Finance Watch: Venture Floodgates Open With New Funds, Dozens Of Rounds
VC Firms Commit More Than $1.9bn To Future Investments
Private Company Edition: While the tough state of financing for publicly traded drug developers continues, venture capital firms and private biopharma companies revealed billions of dollars in new VC funds and start-up financings, including $100m-plus mega-rounds for Tessa, Alladapt and ImCheck.
